Publication:
Pharmacoresistance in psychiatry

dc.contributor.authorsAricioglu, Feyza
dc.date.accessioned2022-03-12T17:36:29Z
dc.date.accessioned2026-01-11T08:18:40Z
dc.date.available2022-03-12T17:36:29Z
dc.date.issued2009
dc.description.abstractPharmacoresistance (resistance to treatment) is one of the major problems in psychiatry although several new drugs come into clinical practice every day. There is a role of genetic factors, change in cellular response and change in nature of the disorder in patients who are individually treatment resistant. It is important to understand reasons of pharmacoresistance not only for effectiveness but also for polypharmacy required situations and for pharmacoeconomy. The more we learn about pharmacoresistance it will be possible to consider all factors from drugs, patients and disease therefore, rational drug use and/or rational polipharmacy will be provided.
dc.identifier.doidoiWOS:000209020900009
dc.identifier.issn1017-7833
dc.identifier.urihttps://hdl.handle.net/11424/229274
dc.identifier.wosWOS:000209020900009
dc.language.isotur
dc.publisherKURE ILETISIM GRUBU A S
dc.relation.ispartofKLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectCYP 450 enzymes
dc.subjectmonoamine transporters
dc.subjectG proteins
dc.subjectP-glycoprotein
dc.subjectMultidrug resistance protein
dc.subjectdrug interactions
dc.subjectneuroplasticity
dc.subjectneurotrophins
dc.subjectcytokines
dc.subjectBIPOLAR DISORDER
dc.subjectSCHIZOPHRENIA
dc.subjectPOLYMORPHISMS
dc.subjectASSOCIATION
dc.subjectGENES
dc.subjectPLASTICITY
dc.subjectFEMALES
dc.subjectBRAIN
dc.subjectDRUGS
dc.titlePharmacoresistance in psychiatry
dc.typearticle
dspace.entity.typePublication
oaire.citation.endPageS53
oaire.citation.startPageS43
oaire.citation.titleKLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY
oaire.citation.volume19

Files